These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 8994122)

  • 41. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
    Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
    Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitation of T-cell receptor V beta chain expression on lymphocytes from blood, brain, and spinal fluid in patients with multiple sclerosis and other neurological diseases.
    Birnbaum G; van Ness B
    Ann Neurol; 1992 Jul; 32(1):24-30. PubMed ID: 1386501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity.
    Drulović J; Dujmović I; Mesaros S; Samardzić T; Maksimović D; Stojsavljević N; Lević Z; Mostarica Stojokvić M
    Mult Scler; 2001 Feb; 7(1):19-22. PubMed ID: 11321188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
    Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
    J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gamma delta T cell distribution in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis.
    Droogan AG; Crockard AD; Hawkins SA; McNeill TA
    J Neurol Sci; 1994 Nov; 126(2):172-7. PubMed ID: 7853024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD4+ lymphocyte subsets in the cerebrospinal fluid of multiple sclerosis and non-inflammatory neurological diseases.
    Zaffaroni M; Gallo L; Ghezzi A; Cazzullo CL
    J Neurol; 1991 Jul; 238(4):209-11. PubMed ID: 1680167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Neurological adverse events under anti-TNF alpha therapy].
    Cohen M; Baldin B; Thomas P; Lebrun C
    Rev Neurol (Paris); 2012 Jan; 168(1):33-9. PubMed ID: 22098827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
    Kuroda H; Fujihara K; Takano R; Takai Y; Takahashi T; Misu T; Nakashima I; Sato S; Itoyama Y; Aoki M
    J Neuroimmunol; 2013 Jan; 254(1-2):178-82. PubMed ID: 23017732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
    Albanese M; Zagaglia S; Landi D; Boffa L; Nicoletti CG; Marciani MG; Mandolesi G; Marfia GA; Buttari F; Mori F; Centonze D
    J Neuroinflammation; 2016 Feb; 13():36. PubMed ID: 26863878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis.
    Callea L; Arese M; Orlandini A; Bargnani C; Priori A; Bussolino F
    J Neuroimmunol; 1999 Feb; 94(1-2):212-21. PubMed ID: 10376955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
    Wurth S; Kuenz B; Bsteh G; Ehling R; Di Pauli F; Hegen H; Auer M; Gredler V; Deisenhammer F; Reindl M; Berger T
    PLoS One; 2017; 12(8):e0182462. PubMed ID: 28777826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Magnetic resonance spectroscopy and its clinical applications in multiple sclerosis].
    Watanabe H; Fukatsu H; Ito T; Iijima M; Mabuchi N; Sobue G
    Nihon Rinsho; 2003 Aug; 61(8):1435-41. PubMed ID: 12962035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proliferating cells in demyelinating states.
    Reunanen MI; Ilonen J; Järvenpää K
    Adv Exp Med Biol; 1978; 100():561-8. PubMed ID: 696480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
    Fainardi E; Castellazzi M; Bellini T; Manfrinato MC; Baldi E; Casetta I; Paolino E; Granieri E; Dallocchio F
    Mult Scler; 2006 Jun; 12(3):294-301. PubMed ID: 16764342
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CSF lactate level: a useful diagnostic tool to differentiate acute bacterial and viral meningitis.
    Abro AH; Abdou AS; Ustadi AM; Saleh AA; Younis NJ; Doleh WF
    J Pak Med Assoc; 2009 Aug; 59(8):508-11. PubMed ID: 19757692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo.
    Bruhn H; Frahm J; Merboldt KD; Hänicke W; Hanefeld F; Christen HJ; Kruse B; Bauer HJ
    Ann Neurol; 1992 Aug; 32(2):140-50. PubMed ID: 1324631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis.
    Tourbah A; Stievenart JL; Gout O; Fontaine B; Liblau R; Lubetzki C; Cabanis EA; Lyon-Caen O
    Neurology; 1999 Sep; 53(5):1091-7. PubMed ID: 10496272
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients correlates with hypointense lesions on T1 magnetic resonance imaging.
    Cid C; Alcázar A; Regidor I; Masjuan J; Salinas M; Alvarez-Cermeño JC
    J Neurol Sci; 2002 Jan; 193(2):103-9. PubMed ID: 11790390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.